文献速递骨质疏松与钙磷/甲状旁腺

原发性甲状旁腺功能亢进症术后长期复发率

Long-term Recurrence Rates After Surgery in Primary Hyperparathyroidism.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

该系统综述与Meta分析纳入34项观察性研究、30 658例散发性原发性甲状旁腺功能亢进症患者,术后总复发率为1.56%(95%CI 0.96-2.28%;I²=91%),5年和10年复发率分别为0.23%(0.04-0.53%;I²=66%)和1.03%(0.45-1.80%;I²=89%)。敏感性分析未发现研究规模、诊断或手术方式对复发率有统计学显著影响,作者认为需要一致的长期随访以识别复发病例。

要点

  • 散发性原发性甲状旁腺功能亢进症术后总复发率为1.56%(95%CI 0.96-2.28%)。
  • 术后5年复发率为0.23%(95%CI 0.04-0.53%),10年复发率为1.03%(95%CI 0.45-1.80%)。
  • 敏感性分析未发现研究规模、诊断或手术方式对复发率有统计学显著影响。

核心结论

  • 约1.56%的散发性原发性甲状旁腺功能亢进症患者在接受甲状旁腺切除术后最终出现复发。
  • 初始诊断和手术方式不影响复发率。
  • 需要一致的长期随访以帮助识别复发性疾病。

研究设计与样本

  • 系统综述与Meta分析,检索多个数据库(包括PubMed、EMBASE、Cochrane、EBSCO-CINHAL、Ovid、Scopus和Google Scholar)自建库至2023年1月18日。
  • 纳入报告术后至少5年随访数据的观察性研究。
  • 初检5769篇文章,242篇全文审查,最终34篇符合纳入标准。
  • 共纳入30 658例参与者,其中350例(1.1%)术后出现复发。
  • 两名作者独立提取数据并使用美国国立卫生研究院研究质量评估工具进行质量评价。

主要发现

  • 总复发率的合并估计值为1.56%(95%CI 0.96-2.28%;I²=91%)。
  • 术后5年复发率的合并估计值为0.23%(95%CI 0.04-0.53%;19项研究;I²=66%)。
  • 术后10年复发率的合并估计值为1.03%(95%CI 0.45-1.80%;14项研究;I²=89%)。
  • 敏感性分析在调整研究规模、诊断或手术方式后未发现统计学显著差异。

关键数值与推荐

  • 总体复发率合并估计值为1.56%(95%CI 0.96-2.28%;I²=91%)。
  • 5年复发率合并估计值为0.23%(95%CI 0.04-0.53%;19项研究;I²=66%)。
  • 10年复发率合并估计值为1.03%(95%CI 0.45-1.80%;14项研究;I²=89%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 总体复发率合并估计存在显著异质性(I²=91%)。
  • 5年复发率合并估计存在中度异质性(I²=66%)。
  • 10年复发率合并估计存在显著异质性(I²=89%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Primary hyperparathyroidism (PHPT) is the most common cause of hypercalcemia, yet long-term (5- and 10-year) recurrence rates after curative surgery have been unclear. OBJECTIVE: To perform the first systematic review and meta-analysis investigating the long-term recurrence rates of sporadic PHPT after successful parathyroidectomy. METHODS: A comprehensive search of multiple databases (including PubMed, EMBASE, Cochrane, EBSCO-CINHAL, EMBASE, Ovid, Scopus, and Google Scholar) was performed from each database's inception to January 18, 2023. Observational studies reporting at least 5 years of follow-up data after surgical resection were included. Two reviewers independently screened articles for relevance. Of 5769 articles initially identified, 242 were examined in full-text review and 34 were deemed eligible for inclusion. Two authors independently performed data extraction and study appraisal, using the National Institutes of Health study quality assessment tools. RESULTS: Of 30 658 participants, 350 patients (1.1%) experienced recurrence after resection. A meta-analysis of proportions was performed to obtain the pooled recurrence rates. The pooled estimate for overall recurrence rate was 1.56% (95% CI 0.96-2.28%; I2 = 91%). The pooled estimates for 5- and 10-year recurrence rate after resection were 0.23% (0.04-0.53%, 19 studies; I2 = 66%) and 1.03% (0.45-1.80%, 14 studies; I2 = 89%), respectively. Sensitivity analyses did not find a statistically significant difference when adjusting for study size, diagnosis, or surgical approach. CONCLUSION: Approximately 1.56% of sporadic PHPT patients eventually develop recurrence following parathyroidectomy. The initial diagnosis and procedure type does not influence recurrence rates. Consistent long-term follow-up is warranted to help identify recurrent disease.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Zaman M, Raveendran L, Senay A, et al. Long-term Recurrence Rates After Surgery in Primary Hyperparathyroidism. J Clin Endocrinol Metab. 2023. PMID: 37279502. doi:10.1210/clinem/dgad316

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。